Literature DB >> 9304876

On the safety of Mortierella alpina for the production of food ingredients, such as arachidonic acid.

H Streekstra1.   

Abstract

Mortierella alpina is the most efficient production organism for arachidonic acid (AA) presently known. Since AA is being developed as a food ingredient, and since M. alpina has no history of use for such applications, we have undertaken this safety evaluation. M. alpina is a common soil fungus, to which humans are frequently exposed. The production strains are non-pathogenic and do not form potentially allergenic spores under production conditions. Moreover, there are no reliable reports in the literature connecting the species with disease or allergenic responses. No production of mycotoxins was observed, in line with the absence of literature reports describing such products, and with the results of toxicological tests. On solid growth media the strains showed antibiotic activity against Gram-positive bacteria. In submerged culture, which is used for AA production, no significant antibiotic activity was found. We conclude that M. alpina in general, and the AA production strains CBS 168.95 and CBS 169.95 in particular, should be considered safe for the submerged production of food ingredients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9304876     DOI: 10.1016/s0168-1656(97)00109-0

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  8 in total

1.  Isolation and biological activities of an endophytic Mortierella alpina strain from the Antarctic moss Schistidium antarctici.

Authors:  Itamar S Melo; Suikinai N Santos; Luiz H Rosa; Marcia M Parma; Leonardo J Silva; Sonia C N Queiroz; Vivian H Pellizari
Journal:  Extremophiles       Date:  2013-10-15       Impact factor: 2.395

2.  Deletion of the KU70 homologue facilitates gene targeting in Lipomyces starkeyi strain NRRL Y-11558.

Authors:  Ziyu Dai; Kyle R Pomraning; Shuang Deng; Beth A Hofstad; Ellen A Panisko; Diana Rodriguez; Mark G Butcher; David E Culley; Jon K Magnuson
Journal:  Curr Genet       Date:  2018-08-18       Impact factor: 3.886

Review 3.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 4.  Δ6 fatty acid desaturases in polyunsaturated fatty acid biosynthesis: insights into the evolution, function with substrate specificities and biotechnological use.

Authors:  Jie Cui; Haiqin Chen; Xin Tang; Jianxin Zhao; Hao Zhang; Yong Q Chen; Wei Chen
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-23       Impact factor: 4.813

5.  Genome characterization of the oleaginous fungus Mortierella alpina.

Authors:  Lei Wang; Wei Chen; Yun Feng; Yan Ren; Zhennan Gu; Haiqin Chen; Hongchao Wang; Michael J Thomas; Baixi Zhang; Isabelle M Berquin; Yang Li; Jiansheng Wu; Huanxin Zhang; Yuanda Song; Xiang Liu; James S Norris; Suriguga Wang; Peng Du; Junguo Shen; Na Wang; Yanlin Yang; Wei Wang; Lu Feng; Colin Ratledge; Hao Zhang; Yong Q Chen
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

6.  Reconstruction and analysis of a genome-scale metabolic model of the oleaginous fungus Mortierella alpina.

Authors:  Chao Ye; Nan Xu; Haiqin Chen; Yong Q Chen; Wei Chen; Liming Liu
Journal:  BMC Syst Biol       Date:  2015-01-13

7.  Application of a ω-3 Desaturase with an Arachidonic Acid Preference to Eicosapentaenoic Acid Production in Mortierella alpina.

Authors:  Chengfeng Ge; Haiqin Chen; Tiantian Mei; Xin Tang; Lulu Chang; Zhennan Gu; Hao Zhang; Wei Chen; Yong Q Chen
Journal:  Front Bioeng Biotechnol       Date:  2018-01-22

8.  Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial.

Authors:  Angela M Devlin; Cecil M Y Chau; Roger Dyer; Julie Matheson; Deanna McCarthy; Karin Yurko-Mauro; Sheila M Innis; Ruth E Grunau
Journal:  Nutrients       Date:  2017-09-06       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.